Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure

2003 ◽  
Vol 145 (2) ◽  
pp. S51-S54 ◽  
Author(s):  
Mihai Gheorghiade ◽  
Wendy A. Gattis ◽  
Alejandro Barbagelata ◽  
Kirkwood F. Adams ◽  
Uri Elkayam ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Study Design ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

Randomized, Double-Blind, Placebo-Controlled Study of Supplemental Oral l -Arginine in Patients With Heart Failure

Circulation ◽  
1996 ◽  
Vol 93 (12) ◽  
pp. 2135-2141 ◽  
Author(s):  
Thomas S. Rector ◽  
Alan J. Bank ◽  
Kathleen A. Mullen ◽  
Linda K. Tschumperlin ◽  
Ronald Sih ◽  
...  
Keyword(s):  
Heart Failure ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Patients With Heart Failure

scholarly journals Double blind, placebo-controlled study of long-term intermittent dobutamine infusion with concomitant oral amiodarone for end stage heart failure

2003 ◽  
Vol 41 (6) ◽  
pp. 162-163
Author(s):  
Eleftheria Tsagalou ◽  
Maria Anastasiou-Nana ◽  
George Alexopoulos ◽  
John Terrovitis ◽  
Konstantinos Chalkias ◽  
...  
Keyword(s):  
Heart Failure ◽  
Dobutamine Infusion ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
End Stage Heart Failure ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document